KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Current Assets (2016 - 2026)

Neogenomics filings provide 17 years of Current Assets readings, the most recent being $373.7 million for Q1 2026.

  • On a quarterly basis, Current Assets fell 34.89% to $373.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $373.7 million, a 34.89% decrease, with the full-year FY2025 number at $376.3 million, down 36.87% from a year prior.
  • Current Assets hit $373.7 million in Q1 2026 for Neogenomics, down from $376.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $651.1 million in Q1 2022 to a low of $373.7 million in Q1 2026.
  • Median Current Assets over the past 5 years was $585.0 million (2023), compared with a mean of $545.8 million.
  • Biggest five-year swings in Current Assets: rose 0.56% in 2024 and later tumbled 36.87% in 2025.
  • Neogenomics' Current Assets stood at $605.3 million in 2022, then dropped by 1.4% to $596.8 million in 2023, then dropped by 0.13% to $596.0 million in 2024, then tumbled by 36.87% to $376.3 million in 2025, then decreased by 0.69% to $373.7 million in 2026.
  • The last three reported values for Current Assets were $373.7 million (Q1 2026), $376.3 million (Q4 2025), and $382.5 million (Q3 2025) per Business Quant data.